Political science

Neisseria meningitidis

Bacteria

Biology

Astronomy

Vaccination

Immunology

Public administration

Meningococcal disease

Genetics

Medicine

Immunization

Family medicine

Outbreak

Meningococcal vaccine

Virology

Antibody

Booster (rocketry)

Advisory committee

Physics

Booster dose

Pediatrics

MMWR Recommendations and Reports

This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) for use of meningococcal vaccines in the United States. As a comprehensive summary and update of previously published recommendations, it replaces all previously published reports and policy notes. This report also contains new recommendations for administration of booster doses of serogroup B meningococcal (MenB) vaccine for persons at increased risk for serogroup B meningococcal disease. These guidelines will be updated as needed on the basis of availability of new data or licensure of new meningococcal vaccines. ACIP recommends routine vaccination with a quadrivalent meningococcal conjugate vaccine (MenACWY) for adolescents aged 11 or 12 years, with a booster dose at age 16 years. ACIP also recommends routine vaccination with MenACWY for persons aged ≥2 months at increased risk for meningococcal disease caused by serogroups A, C, W, or Y, including persons who have persistent complement co...

Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020